BEZLOTOXUMAB

BEZLOTOXUMAB was reported 350 times

BEZLOTOXUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AVIAN INFLUENZA 13 0.2031
1 HYPERGLYCAEMIC CRISIS 9 0.1731
2 RENAL GRAFT INFECTION 13 0.0560
3 PROBIOTIC THERAPY 5 0.0505
4 PSEUDOPOLYP 9 0.0250
5 DIABETIC GASTROPARESIS 9 0.0245
6 URINARY TRACT INFECTION PSEUDOMONAL 13 0.0216
7 ISCHAEMIC ENTERITIS 2 0.0206
8 HEPATOBILIARY CANCER 1 0.0167
9 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 4 0.0134
10 ESCHERICHIA TEST POSITIVE 9 0.0075
11 CLOSTRIDIUM TEST POSITIVE 16 0.0072
12 CLOSTRIDIUM DIFFICILE INFECTION 129 0.0059
13 ENTHESOPATHY 9 0.0058
14 ROTAVIRUS INFECTION 3 0.0052
15 ADENOVIRUS INFECTION 13 0.0045
16 LASER THERAPY 1 0.0044
17 PARENTERAL NUTRITION 1 0.0043
18 CHRONIC DISEASE 1 0.0039
19 CULTURE STOOL POSITIVE 1 0.0036
20 ENTEROCOLITIS BACTERIAL 1 0.0036
21 CLOSTRIDIUM COLITIS 4 0.0033
22 ADENOCARCINOMA GASTRIC 3 0.0032
23 ARRHYTHMIC STORM 1 0.0030
24 GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
25 KLEBSIELLA INFECTION 13 0.0026
26 ESCHERICHIA BACTERAEMIA 6 0.0025
27 PSEUDOMONAL BACTERAEMIA 2 0.0023
28 COLON NEOPLASM 2 0.0021
29 CARDIAC VALVE VEGETATION 1 0.0021
30 CLOSTRIDIUM DIFFICILE COLITIS 21 0.0020
31 RESPIRATORY TRACT INFECTION FUNGAL 1 0.0019
32 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 4 0.0019
33 COLECTOMY TOTAL 1 0.0018
34 LUNG INFECTION PSEUDOMONAL 1 0.0018
35 HEAD BANGING 1 0.0018
36 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
37 PLASMA CELL LEUKAEMIA 1 0.0017
38 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
39 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
40 VASCULITIS NECROTISING 1 0.0014
41 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
42 PSEUDOMEMBRANOUS COLITIS 3 0.0013
43 ESCHERICHIA INFECTION 11 0.0013
44 PANCREATITIS NECROTISING 3 0.0013
45 FUNGAL SEPSIS 1 0.0012
46 TONGUE PRURITUS 1 0.0012
47 TRANSFUSION REACTION 1 0.0011
48 HYPERVIGILANCE 1 0.0010
49 HYPOFIBRINOGENAEMIA 1 0.0010
50 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
51 KLEBSIELLA SEPSIS 1 0.0009
52 LABILE BLOOD PRESSURE 1 0.0008
53 BLOOD UREA DECREASED 1 0.0008
54 STENOTROPHOMONAS INFECTION 1 0.0007
55 PULMONARY SEPSIS 1 0.0007
56 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
57 GASTROSTOMY 1 0.0006
58 PSEUDOMONAL SEPSIS 1 0.0006
59 BODY TEMPERATURE ABNORMAL 1 0.0005
60 NEUTROPHILIA 3 0.0005
61 TREATMENT FAILURE 43 0.0005
62 INFUSION SITE EXTRAVASATION 3 0.0005
63 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
64 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
65 TRANSPLANT 1 0.0004
66 STARING 1 0.0004
67 MUCOUS STOOLS 2 0.0004
68 ORGANISING PNEUMONIA 2 0.0004
69 STEM CELL TRANSPLANT 1 0.0004
70 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
71 GASTROINTESTINAL INJURY 1 0.0004
72 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
73 SYMPTOM RECURRENCE 2 0.0003
74 EMERGENCY CARE 1 0.0003
75 PRODUCT PRESCRIBING ISSUE 7 0.0003
76 PANCREATITIS ACUTE 7 0.0003
77 LIVER TRANSPLANT 1 0.0003
78 COLITIS ULCERATIVE 12 0.0003
79 TONGUE OEDEMA 1 0.0003
80 BOWEL MOVEMENT IRREGULARITY 2 0.0003
81 LEG AMPUTATION 1 0.0002
82 HALLUCINATIONS, MIXED 1 0.0002
83 LIP OEDEMA 1 0.0002
84 AORTIC VALVE INCOMPETENCE 1 0.0002
85 ILEUS PARALYTIC 1 0.0002
86 HEPATOCELLULAR INJURY 3 0.0002
87 CARDIAC TAMPONADE 1 0.0002
88 STAPHYLOCOCCAL SEPSIS 1 0.0002
89 CEREBRAL ISCHAEMIA 1 0.0002
90 TONSILLITIS 1 0.0002
91 TIC 1 0.0002
92 COLECTOMY 1 0.0002
93 ENTEROCOLITIS 1 0.0002
94 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
95 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
96 PNEUMONIA ASPIRATION 4 0.0002
97 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
98 HYPOGAMMAGLOBULINAEMIA 1 0.0002
99 RESPIRATION ABNORMAL 1 0.0001
100 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
101 PRODUCT SUPPLY ISSUE 1 0.0001
102 ORAL DISORDER 1 0.0001
103 PRODUCT AVAILABILITY ISSUE 3 0.0001
104 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
105 HYPOALBUMINAEMIA 1 0.0001
106 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
107 ATRIAL FLUTTER 1 0.0001
108 FRUSTRATION TOLERANCE DECREASED 1 0.0001
109 LIVER INJURY 3 0.0001
110 CYTOMEGALOVIRUS INFECTION 2 0.0001
111 VITAMIN D DECREASED 1 0.0001
112 CARDIAC FAILURE 9 0.0001
113 ADVERSE EVENT 10 0.0001
114 CONJUNCTIVITIS 2 0.0001
115 DIARRHOEA HAEMORRHAGIC 1 0.0001
116 LEUKAEMIA 1 0.0001
117 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
118 HYPOCALCAEMIA 2 0.0001
119 COLITIS 4 0.0001
120 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
121 CARDIO-RESPIRATORY ARREST 4 0.0001
122 INCONTINENCE 1 0.0001
123 DECREASED ACTIVITY 1 0.0001
124 SEPTIC SHOCK 4 0.0001
125 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
126 GASTROINTESTINAL PAIN 1 0.0001
127 MALNUTRITION 1 0.0001
128 MYOCARDIAL ISCHAEMIA 1 0.0001
129 CHOLECYSTECTOMY 1 0.0001
130 PERICARDIAL EFFUSION 2 0.0001
131 RESPIRATORY FAILURE 6 0.0001
132 MUSCLE SPASTICITY 1 0.0001
133 ILEUS 1 0.0001
134 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
135 INFLAMMATION 4 0.0001
136 BEDRIDDEN 1 0.0001
137 INFUSION RELATED REACTION 5 0.0001
138 RESPIRATORY DISTRESS 2 0.0001
139 HAEMORRHAGE INTRACRANIAL 1 0.0001
140 THERAPY NON-RESPONDER 3 0.0001
141 HEPATIC FAILURE 2 0.0001
142 DEVICE RELATED INFECTION 1 0.0001
143 LYMPHOMA 1 0.0001
144 URINARY TRACT INFECTION 11 0.0001
145 ARTHRITIS 5 0.0001
146 FEBRILE NEUTROPENIA 4 0.0001
147 COAGULOPATHY 1 0.0001
148 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
149 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
150 THERAPY CESSATION 3 0.0001
151 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
152 GASTRIC DISORDER 2 0.0001
153 NEUROTOXICITY 1 0.0001
154 PRODUCT USE IN UNAPPROVED INDICATION 14 0.0001
155 DRUG INEFFECTIVE 72 0.0001
156 HEPATIC FUNCTION ABNORMAL 2 0.0001
157 DRUG PRESCRIBING ERROR 1 0.0001
158 PYREXIA 18 0.0001
159 ACUTE RESPIRATORY FAILURE 1 0.0001
160 BLOOD PRESSURE ABNORMAL 1 0.0001
161 PRODUCT ADMINISTRATION ERROR 1 0.0000
162 ILL-DEFINED DISORDER 3 0.0000
163 BODY TEMPERATURE INCREASED 1 0.0000
164 EATING DISORDER 1 0.0000
165 IMPAIRED WORK ABILITY 1 0.0000
166 RASH MACULO-PAPULAR 1 0.0000
167 DIARRHOEA 29 0.0000
168 THROMBOCYTOPENIA 5 0.0000
169 MUSCLE TWITCHING 1 0.0000
170 DISEASE RECURRENCE 2 0.0000
171 CEREBRAL INFARCTION 1 0.0000
172 ENCEPHALOPATHY 1 0.0000
173 CHRONIC KIDNEY DISEASE 3 0.0000
174 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
175 UNRESPONSIVE TO STIMULI 1 0.0000
176 THROAT TIGHTNESS 1 0.0000
177 PALLOR 1 0.0000
178 MOOD ALTERED 1 0.0000
179 MENTAL STATUS CHANGES 1 0.0000
180 HAEMOPTYSIS 1 0.0000
181 FLATULENCE 2 0.0000
182 PAIN IN EXTREMITY 10 0.0000
183 ACUTE MYOCARDIAL INFARCTION 1 0.0000
184 APHASIA 1 0.0000
185 CORONARY ARTERY DISEASE 1 0.0000
186 PLEURAL EFFUSION 2 0.0000
187 EPILEPSY 1 0.0000
188 PRODUCT USE ISSUE 6 0.0000
189 PULMONARY EMBOLISM 3 0.0000
190 MOVEMENT DISORDER 1 0.0000
191 STAPHYLOCOCCAL INFECTION 1 0.0000
192 DELIRIUM 1 0.0000
193 ABDOMINAL DISTENSION 3 0.0000
194 RASH MACULAR 1 0.0000
195 HYPOXIA 1 0.0000
196 CEREBRAL HAEMORRHAGE 1 0.0000
197 VOMITING 13 0.0000
198 NO ADVERSE EVENT 5 0.0000
199 C-REACTIVE PROTEIN INCREASED 1 0.0000
200 PANIC ATTACK 1 0.0000
201 UNDERDOSE 2 0.0000
202 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
203 ABORTION SPONTANEOUS 1 0.0000
204 HYPOTENSION 5 0.0000
205 URTICARIA 4 0.0000
206 ABDOMINAL DISCOMFORT 4 0.0000
207 RENAL IMPAIRMENT 2 0.0000
208 ANGIOEDEMA 1 0.0000
209 NEUTROPENIA 3 0.0000
210 DEATH 19 0.0000
211 HYPOKALAEMIA 1 0.0000
212 NAUSEA 17 0.0000
213 BLOOD CHOLESTEROL INCREASED 1 0.0000
214 COGNITIVE DISORDER 1 0.0000
215 ARRHYTHMIA 1 0.0000
216 INFECTION 3 0.0000
217 DRUG INTOLERANCE 2 0.0000
218 INTERSTITIAL LUNG DISEASE 1 0.0000
219 ATRIAL FIBRILLATION 2 0.0000
220 LEUKOPENIA 1 0.0000
221 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
222 NERVOUSNESS 1 0.0000
223 DRUG EFFECT DECREASED 1 0.0000
224 PNEUMONIA 6 0.0000
225 OEDEMA 1 0.0000
226 HAEMATOCHEZIA 1 0.0000
227 NECK PAIN 1 0.0000
228 OXYGEN SATURATION DECREASED 1 0.0000
229 SEIZURE 2 0.0000
230 PALPITATIONS 2 0.0000
231 THERAPEUTIC RESPONSE DECREASED 1 0.0000
232 FEELING HOT 1 0.0000
233 CHEST PAIN 3 0.0000
234 ANAEMIA 3 0.0000
235 SWELLING FACE 1 0.0000
236 RENAL FAILURE 2 0.0000
237 BLOOD PRESSURE DECREASED 1 0.0000
238 HYPERTENSION 3 0.0000
239 DYSPNOEA 8 0.0000
240 OVERDOSE 3 0.0000
241 PRURITUS 5 0.0000
242 CARDIAC FAILURE CONGESTIVE 1 0.0000
243 RASH 5 0.0000
244 OFF LABEL USE 10 0.0000
245 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
246 TACHYCARDIA 1 0.0000
247 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
248 HEADACHE 7 0.0000
249 COUGH 3 0.0000
250 DYSPHAGIA 1 0.0000
251 PRODUCT DOSE OMISSION ISSUE 3 0.0000
252 FLUSHING 1 0.0000
253 CHEST DISCOMFORT 1 0.0000
254 HAEMOGLOBIN DECREASED 1 0.0000
255 ABDOMINAL PAIN UPPER 2 0.0000
256 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
257 MALAISE 4 0.0000
258 SEPSIS 1 0.0000
259 INCORRECT DOSE ADMINISTERED 2 0.0000
260 DECREASED APPETITE 2 0.0000
261 CHILLS 1 0.0000
262 DISEASE PROGRESSION 1 0.0000
263 OEDEMA PERIPHERAL 1 0.0000
264 PAIN 5 0.0000
265 VISUAL IMPAIRMENT 1 0.0000
266 ASTHENIA 3 0.0000
267 BLOOD PRESSURE INCREASED 1 0.0000
268 PARAESTHESIA 1 0.0000
269 DRUG INTERACTION 1 0.0000
270 TREMOR 1 0.0000
271 DIZZINESS 3 0.0000
272 COVID-19 1 0.0000
273 ALOPECIA 1 0.0000
274 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
275 ERYTHEMA 1 0.0000
276 CONSTIPATION 1 0.0000
277 WEIGHT INCREASED 1 0.0000
278 BACK PAIN 1 0.0000
279 ABDOMINAL PAIN 1 0.0000
280 FEELING ABNORMAL 1 0.0000
281 INSOMNIA 1 0.0000
282 WEIGHT DECREASED 1 0.0000
283 CONDITION AGGRAVATED 1 0.0000
284 FATIGUE 2 0.0000
285 ARTHRALGIA 1 0.0000